These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12968095)

  • 1. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.
    Brancazio LR; Murtha AP; Heine RP
    N Engl J Med; 2003 Sep; 349(11):1087-8; author reply 1087-8. PubMed ID: 12968095
    [No Abstract]   [Full Text] [Related]  

  • 2. 17-α hydroxyprogesterone caproate for the prevention of preterm birth.
    Gupta S; Roman AS
    Womens Health (Lond); 2012 Jan; 8(1):21-30. PubMed ID: 22171770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.
    Hartikainen-Sorri AL; Kauppila A; Tuimala R
    Obstet Gynecol; 1980 Dec; 56(6):692-5. PubMed ID: 7443111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
    Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
    Odibo AO; Stamilio DM; Macones GA; Polsky D
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):492-9. PubMed ID: 16946206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does progesterone treatment influence risk factors for recurrent preterm delivery?
    Meis PJ; Klebanoff M; Dombrowski MP; Sibai BM; Leindecker S; Moawad AH; Northen A; Iams JD; Varner MW; Caritis SN; O'Sullivan MJ; Miodovnik M; Leveno KJ; Conway D; Wapner RJ; Carpenter M; Mercer B; Ramin SM; Thorp JM; Peaceman AM; Gabbe S
    Obstet Gynecol; 2005 Sep; 106(3):557-61. PubMed ID: 16135587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.
    Feghali M; Venkataramanan R; Caritis S
    Semin Perinatol; 2014 Dec; 38(8):516-22. PubMed ID: 25256193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.
    Rozenberg P; Chauveaud A; Deruelle P; Capelle M; Winer N; Desbrière R; Perrotin F; Bohec C; Connan L; Vayssière C; Langer B; Mantel A; Azimi S; Porcher R; Azria E;
    Am J Obstet Gynecol; 2012 Mar; 206(3):206.e1-9. PubMed ID: 22381603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate.
    Yemini M; Borenstein R; Dreazen E; Apelman Z; Mogilner BM; Kessler I; Lancet M
    Am J Obstet Gynecol; 1985 Mar; 151(5):574-7. PubMed ID: 3976757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report.
    Ng KS; Ng BK; Lim PS; Shafiee MN; Abdul Karim AK; Omar MH
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):89-91. PubMed ID: 26684353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?
    How HY; Barton JR; Istwan NB; Rhea DJ; Stanziano GJ
    Am J Obstet Gynecol; 2007 Sep; 197(3):260.e1-4. PubMed ID: 17826411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.
    Saghafi N; Khadem N; Mohajeri T; Shakeri MT
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1342-5. PubMed ID: 21564406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent hope for the treatment of preterm delivery.
    Doggrell SA
    Expert Opin Pharmacother; 2003 Dec; 4(12):2363-6. PubMed ID: 14640934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the efficiency of hydroxyprogesterone caproate and of chlormadinone acetate in the prevention of premature labor.
    Bréart G; Lanfranchi M; Chavigny C; Rumeau-Rouquette C; Sureau C
    Int J Gynaecol Obstet; 1979; 16(5):381-4. PubMed ID: 86468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?
    Manuck TA
    Semin Perinatol; 2017 Dec; 41(8):461-467. PubMed ID: 28947068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caproate: a comparison with ritodrine.
    Kauppila A; Hartikainen-Sorri AL; Jänne O; Tuimala R; Järvinen PA
    Am J Obstet Gynecol; 1980 Oct; 138(4):404-8. PubMed ID: 7424996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestogen administration in pregnancy may prevent preterm delivery.
    Keirse MJ
    Br J Obstet Gynaecol; 1990 Feb; 97(2):149-54. PubMed ID: 2138496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage.
    Rebarber A; Cleary-Goldman J; Istwan NB; Rhea DJ; Desch C; Russo-Stieglitz K; Saltzman DH
    Am J Perinatol; 2008 May; 25(5):271-5. PubMed ID: 18401840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ricinus oil for labor induction].
    Lippert TH
    Z Geburtshilfe Neonatol; 1997; 201(2):73. PubMed ID: 9235286
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
    Facchinetti F; Vaccaro V
    Minerva Ginecol; 2009 Oct; 61(5):401-9. PubMed ID: 19749671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.